๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Future perspectives for acute promyelocytic leukemia therapy

โœ Scribed by Bruno Cassinat; Christine Chomienne

Book ID
117211213
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
707 KB
Volume
38
Category
Article
ISSN
1532-8686

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Prophylactic heparin therapy in acute pr
Prophylactic heparin therapy in acute promyelocytic leukemia
โœ Robert L. Drapkin; Timothy S. Gee; Monroe D. Dowling; Zalmen Arlin; Susan McKenz ๐Ÿ“‚ Article ๐Ÿ“… 1978 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 424 KB ๐Ÿ‘ 2 views

Twenty-four patients with acute promyelocytic leukemia were reviewed. Group I, treated between July 1970 and September 1973, received arabinosylcytosine and 6-thioguanine, and there was one complete remission, with 4 7 dying during induction with intracerebral hemorrhages, and 217 dying within one m

Morphologic heterogeneity of acute promy
Morphologic heterogeneity of acute promyelocytic leukemia: Therapy-related acute promyelocytic leukemia presenting with FAB-M2 morphology
โœ S. Sinha; L. Aish; T.H. Oo ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 285 KB ๐Ÿ‘ 1 views

To the Editor: Translocation t(9;22)(q34;q11) is found in 1-2% of newly diagnosed patients with de novo AML. The prognosis of Ph รพ AML is very poor with a median survival time of only 7 months. We present two patients with de novo Ph รพ AML who received induction chemotherapy and post-remission imati